NICE Appraisal Changes: Confusing, Contradictory & Questionable

 
• By Lucie Ellis-Taitt

New NICE and NHS England appraisal rules regarding timelines and price thresholds could fast-track new cost-effective drugs but then delay them from reaching patients for up to three years. The new regulations, which will come into force in April, have raised a lot of questions around methodology and impact outside of England.

Exclamation marks and question marks
Concerns and questions have been raised over new UK HTA rules • Source: Shutterstock

More from Pricing Debate

More from Market Access